Michel Fortin, President & CEO, Prevtec Microbia

1

Partnerships andBusiness Development

in Asia

2

Canadian biotechnology company developing biological products to improve animal health and increase animal production performance. • Products distributed Worldwide:

Coliprotec®

• Pipeline of three additional technologies

3

Prepare for a Tsunami of Change 

4

The Wave of Global Hunger

Credit to Jeff Simmons, CEO of Elanco

5

Daily Talk in the News

….Since the resistance was found in humans in

relatively few cases – when compared to animals,

that is – it looks probable that this type of

resistance originated in animals and was

transferred to humans, explained the Prof

Jianzhong Shen, one of the authors of the

research and attached to the Beijing

Advanced Innovation Center for Food

Nutrition and Animal Health at the China

Agricultural University.

Tues., Jan. 5, 2016The alarming drug-resistance gene MCR-1 that was first detected in China in November has been found in meat sold in Ontario in 2010, the Star has learned. The gene grants bacteria like E. coli resistance to colistin, a powerful antibiotic of last resort.

6

March 4, 2015McDonald’s U.S. restaurants will gradually stop buying chicken raised with antibiotics vital to fighting human infections, the most aggressive step by a major food company to force chicken producers to change practices in the fight against dangerous “superbugs.” (Shannon Stapleton/Reuters)

October 4, 2016

A new federal policy aimed at reducing the unnecessary use of

antibiotics in agriculture may not be as effective as officials

intended — at least in the near-term — in addressing the

alarming rise in drug resistance, a new report suggests.

Beginning Jan. 1, the Food and Drug Administration will impose a

voluntary ban on the use of key antibiotics in healthy animals to

promote growth, a practice that is contributing to the spread of

so-called superbugs.While the policy is voluntary, the makers of antibiotics for

animals have agreed to comply, which means that starting next

year food animal producers will no longer be able to simply buy

these antibiotics at their supply stores. Veterinarians will need to

oversee their use.

Daily Talk in the News

7

Strike the right balance in the Animal Health Industry

Economic impact studies (ex) KPMG

Resistance to antibiotics because

of over use

Ban the use of antibiotics

A better way to feed the planet

9

JV with Asian Partner

10

World Pig Production

11

World Pig Production

All other countries... and ChinaUSAGermanyVietnamSpainBrazilRussiaFrancePhilippinesPolandCanadaDenmarkOthers

Sichuan HunanHenanShandongHubeiGuangdongGuanxiHebeiJiangxiYunnanJiangsuAnhuiLiaoningOthers

12

The Situation in China

• Strong growth in production• Increasing industrialization• Food safety is becoming a priority• Need for performance• Once the decision is taken to ensure

sustainable food production, very efficient and fast execution will prevail

13

Rapid, cost efficient and rewarding

Our Business Model

* Contract research organization** Contract manufacturing organization

Scouting for new technologies

Identification of a promising new technology

Proof of concept

Research by CRO* and CMO**

Prototype

Scale-up

Commercial product

Registration process

Registration

Commercializationby distributor

14

Corporate Structure

15

Prevtec’s first patented group of products on the market A family of three vaccines for the swine industry

- Post weaning diarrhea in swine F4-F18- Oedema disease- Performance in production

An efficient alternative to antibiotics

Coliprotec®

16

Our Pipeline of Technologies

• Feed Additive for Swineo Replacing ATB in animal food

• Streptococcus Suiso Multisystemic disease in swine

• Avian E. coli vaccine o Respiratory disease

• Food safety antibodieso For cattle

17

AsianJV

Prevtec Microbia HKLimited

(Hong Kong)

•Technological Transfer•Intellectual Property•Scientific Expertise•Regulatory Process•Coliprotec® Products•Technologies

•Investment $$•Geographic Market Experience & Network•Asian Regulatory Process•Distribution

ASIAN PARTNER

18

The Prevtec Advantage

Proven ability to develop and register vaccines √

Proven ability to generate near term cash in countries with current vaccine regulatory approvals √

Proven team with demonstrated ability to partner with major companies to finance, develop, manufacture and commercialize

√

Potential new products of non-antibiotic, vaccine-related technologies to prevent and treat food animal diseases

√

Poised to become the non-antibiotic, anti-infective "go to" company √

19

Partnering up with the Best

• Animal Pharm Award 2015 Best New Product – food animals

• GOLD LEAF AWARD 2015 - BIOTECanada - Prevtec awarded Emerging Company of the Year

• ADRIQ Innovative Product Award 2015 - Prevtec awarded for its Innovative Product, Coliprotec® F4, bringing a discovery to commercialization in key markets

• ADRIQ 2008 “Coup de coeur” and finalist for its innovation technology

20

Thank You